Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Ataxia
A novel variant of dehydrodolichol diphosphate synthase (DHDDS) mutation with adult-onset progressive myoclonus ataxia.
Blindness
Overexpression and Purification of Human Cis-prenyltransferase in Escherichia coli.
Blindness
Purification and characterization of human dehydrodolychil diphosphate synthase (DHDDS) overexpressed in E. coli.
Blindness
Retinal Degeneration Caused by Rod-Specific Dhdds Ablation Occurs without Concomitant Inhibition of Protein N-Glycosylation.
Brain Diseases
De novo DHDDS variants cause a neurodevelopmental and neurodegenerative disorder with myoclonus.
Breast Neoplasms
Nogo-B receptor expression correlates negatively with malignancy grade and ki-67 antigen expression in invasive ductal breast carcinoma.
Breast Neoplasms
Nogo-B receptor increases the resistance of estrogen receptor positive breast cancer to paclitaxel.
Breast Neoplasms
Nogo-B receptor increases the resistance to tamoxifen in estrogen receptor-positive breast cancer cells.
Carcinogenesis
Nogo-B receptor increases the resistance to tamoxifen in estrogen receptor-positive breast cancer cells.
Carcinogenesis
Research advances on neurite outgrowth inhibitor B receptor.
Carcinoma
Expression of Nogo isoforms and Nogo-B receptor (NgBR) in non-small cell lung carcinomas.
Carcinoma, Hepatocellular
A case of fatal Type I congenital disorders of glycosylation (CDG I) associated with low dehydrodolichol diphosphate synthase (DHDDS) activity.
Carcinoma, Hepatocellular
Nogo-B receptor promotes the chemoresistance of human hepatocellular carcinoma via the ubiquitination of p53 protein.
Carcinoma, Hepatocellular
The Nogo-B receptor promotes human hepatocellular carcinoma cell growth via the Akt signal pathway.
Carcinoma, Non-Small-Cell Lung
Nogo-B receptor is required for stabilizing TGF-? type I receptor and promotes the TGF-?1-induced epithelial-to-mesenchymal transition of non-small cell lung cancer.
Carcinoma, Non-Small-Cell Lung
Nogo-B receptor promotes epithelial-mesenchymal transition in non-small cell lung cancer cells through the Ras/ERK/Snail1 pathway.
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Mutation of Nogo-B receptor, a subunit of cis-prenyltransferase, causes a congenital disorder of glycosylation.
ditrans,polycis-polyprenyl diphosphate synthase [(2e,6e)-farnesyl diphosphate specific] deficiency
A case of fatal Type I congenital disorders of glycosylation (CDG I) associated with low dehydrodolichol diphosphate synthase (DHDDS) activity.
ditrans,polycis-polyprenyl diphosphate synthase [(2e,6e)-farnesyl diphosphate specific] deficiency
Nogo-B receptor deficiency causes cerebral vasculature defects during embryonic development in mice.
ditrans,polycis-polyprenyl diphosphate synthase [(2e,6e)-farnesyl diphosphate specific] deficiency
Nogo-B receptor deficiency increases liver X receptor alpha nuclear translocation and hepatic lipogenesis through an adenosine monophosphate-activated protein kinase alpha-dependent pathway.
Drug Resistant Epilepsy
Complex Neurological Phenotype Associated with a De Novo DHDDS Mutation in a Boy with Intellectual Disability, Refractory Epilepsy, and Movement Disorder.
Epilepsy, Generalized
A novel variant of dehydrodolichol diphosphate synthase (DHDDS) mutation with adult-onset progressive myoclonus ataxia.
Epilepsy, Generalized
Fifteen-year follow-up of a patient with a DHDDS variant with non-progressive early onset myoclonic tremor and rare generalized epilepsy.
Erectile Dysfunction
Silencing Nogo-B receptor inhibits penile corpus cavernosum vascular smooth muscle cell apoptosis of rats with diabetic erectile dysfunction by down-regulating ICAM-1.
Hyperkinesis
Complex Neurological Phenotype Associated with a De Novo DHDDS Mutation in a Boy with Intellectual Disability, Refractory Epilepsy, and Movement Disorder.
Hypertriglyceridemia
Activation of hepatic Nogo-B receptor expression-A new anti-liver steatosis mechanism of statins.
Intellectual Disability
Complex Neurological Phenotype Associated with a De Novo DHDDS Mutation in a Boy with Intellectual Disability, Refractory Epilepsy, and Movement Disorder.
Lung Neoplasms
Nogo-B receptor is required for stabilizing TGF-? type I receptor and promotes the TGF-?1-induced epithelial-to-mesenchymal transition of non-small cell lung cancer.
Lung Neoplasms
Nogo-B receptor promotes epithelial-mesenchymal transition in non-small cell lung cancer cells through the Ras/ERK/Snail1 pathway.
Melanoma
Prognostic Significance of NOGO-A/B and NOGO-B Receptor Expression in Malignant Melanoma - A Preliminary Study.
Movement Disorders
Complex Neurological Phenotype Associated with a De Novo DHDDS Mutation in a Boy with Intellectual Disability, Refractory Epilepsy, and Movement Disorder.
Myoclonus
A novel variant of dehydrodolichol diphosphate synthase (DHDDS) mutation with adult-onset progressive myoclonus ataxia.
Myoclonus
De novo DHDDS variants cause a neurodevelopmental and neurodegenerative disorder with myoclonus.
Neoplasm Metastasis
Delivery of small interfering RNA against Nogo-B receptor via tumor-acidity responsive nanoparticles for tumor vessel normalization and metastasis suppression.
Neoplasms
Correlation of Expression of CHI3L1 and Nogo-A and their Role in Angiogenesis in Invasive Ductal Breast Carcinoma.
Neoplasms
Delivery of small interfering RNA against Nogo-B receptor via tumor-acidity responsive nanoparticles for tumor vessel normalization and metastasis suppression.
Neoplasms
HOXB4 promotes the malignant progression of ovarian cancer via DHDDS.
Neoplasms
Nogo-B Receptor Directs Mitochondria-Associated Membranes to Regulate Vascular Smooth Muscle Cell Proliferation.
Neoplasms
Nogo-B receptor expression correlates negatively with malignancy grade and ki-67 antigen expression in invasive ductal breast carcinoma.
Neurodegenerative Diseases
De novo DHDDS variants cause a neurodevelopmental and neurodegenerative disorder with myoclonus.
Ovarian Neoplasms
HOXB4 promotes the malignant progression of ovarian cancer via DHDDS.
Retinal Degeneration
Knock-Down DHDDS Expression Induces Photoreceptor Degeneration in Zebrafish.
Retinal Degeneration
Knockdown of Dehydrodolichyl Diphosphate Synthase in the Drosophila Retina Leads to a Unique Pattern of Retinal Degeneration.
Retinal Degeneration
Lack of Overt Retinal Degeneration in a K42E Dhdds Knock-In Mouse Model of RP59.
Retinal Degeneration
Mutation K42E in Dehydrodolichol Diphosphate Synthase (DHDDS) Causes Recessive Retinitis Pigmentosa.
Retinal Degeneration
Retinal Degeneration Caused by Rod-Specific Dhdds Ablation Occurs without Concomitant Inhibition of Protein N-Glycosylation.
Retinal Degeneration
Selective Ablation of Dehydrodolichyl Diphosphate Synthase in Murine Retinal Pigment Epithelium (RPE) Causes RPE Atrophy and Retinal Degeneration.
Retinal Diseases
Knockdown of Dehydrodolichyl Diphosphate Synthase in the Drosophila Retina Leads to a Unique Pattern of Retinal Degeneration.
Retinitis
De novo DHDDS variants cause a neurodevelopmental and neurodegenerative disorder with myoclonus.
Retinitis Pigmentosa
A missense mutation in DHDDS, encoding dehydrodolichyl diphosphate synthase, is associated with autosomal-recessive retinitis pigmentosa in Ashkenazi Jews.
Retinitis Pigmentosa
Aberrant dolichol chain lengths as biomarkers for retinitis pigmentosa caused by impaired dolichol biosynthesis.
Retinitis Pigmentosa
De novo DHDDS variants cause a neurodevelopmental and neurodegenerative disorder with myoclonus.
Retinitis Pigmentosa
Knockdown of Dehydrodolichyl Diphosphate Synthase in the Drosophila Retina Leads to a Unique Pattern of Retinal Degeneration.
Retinitis Pigmentosa
Lack of Overt Retinal Degeneration in a K42E Dhdds Knock-In Mouse Model of RP59.
Retinitis Pigmentosa
Mutation K42E in Dehydrodolichol Diphosphate Synthase (DHDDS) Causes Recessive Retinitis Pigmentosa.
Retinitis Pigmentosa
Overexpression and Purification of Human Cis-prenyltransferase in Escherichia coli.
Retinitis Pigmentosa
Purification and characterization of human dehydrodolychil diphosphate synthase (DHDDS) overexpressed in E. coli.
Retinitis Pigmentosa
Retinal Degeneration Caused by Rod-Specific Dhdds Ablation Occurs without Concomitant Inhibition of Protein N-Glycosylation.
Retinitis Pigmentosa
Two specific mutations are prevalent causes of recessive retinitis pigmentosa in North American patients of Jewish ancestry.
Retinitis Pigmentosa
Whole-exome sequencing links a variant in DHDDS to retinitis pigmentosa.
Seizures
Phenotype of heterozygous variants of dehydrodolichol diphosphate synthase.
Status Epilepticus
Phenotype of heterozygous variants of dehydrodolichol diphosphate synthase.
Tremor
Fifteen-year follow-up of a patient with a DHDDS variant with non-progressive early onset myoclonic tremor and rare generalized epilepsy.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Kharel, Y.; Takahashi, S.; Yamashita, S.; Koyama T.
In vivo interaction between the human dehydrodolichyl diphosphate synthase and the Niemann-Pick C2 protein revealed by a yeast two-hybrid system
Biochem. Biophys. Res. Commun.
318
198-203
2004
Homo sapiens
brenda
Endo, S.; Zhang, Y.W.; Takahashi, S.; Koyama, T.
Identification of human dehydrodolichyl diphosphate synthase gene
Biochim. Biophys. Acta
1625
291-295
2003
Homo sapiens (Q86SQ9), Homo sapiens
brenda
Park, E.J.; Grabinska, K.A.; Guan, Z.; Stranecky, V.; Hartmannova, H.; Hodanova, K.; Baresova, V.; Sovova, J.; Jozsef, L.; Ondruskova, N.; Hansikova, H.; Honzik, T.; Zeman, J.; Hulkova, H.; Wen, R.; Kmoch, S.; Sessa, W.C.
Mutation of Nogo-B receptor, a subunit of cis-prenyltransferase, causes a congenital disorder of glycosylation
Cell Metab.
20
448-457
2014
Saccharomyces cerevisiae (Q12063), Saccharomyces cerevisiae, Homo sapiens (Q96E22), Homo sapiens, Mus musculus (Q99LJ8), Schizosaccharomyces pombe (Q9Y7K8), Saccharomyces cerevisiae BY4742 (Q12063)
brenda